1.
Shulgau Z, Kamyshanskiy Y, Gulyayev A. POSSIBILITIES OF USING MEDICINES AND BIOLOGICALLY ACTIVE SUBSTANCES AS CORRECTIVES FOR THE FORMATION OF PULMONARY FIBROSIS DURING SARS-COV-2 INFECTION AND IN THE POST-COVID PERIOD. Eurasian Journal of Applied Biotechnology [Internet]. 2023Apr.13 [cited 2024Apr.24];(1):3-26. Available from: https://biotechlink.org/index.php/journal/article/view/334